Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,653	1,690	2,423	1,628	4,687
Short-Term Investments	760.43	2,997	2,045	-	148.4
Cash & Short-Term Investments	2,413	4,687	4,468	1,628	4,836
Cash Growth	-48.50%	4.88%	174.38%	-66.33%	195.16%
Accounts Receivable	20,022	18,588	16,483	13,085	14,754
Other Receivables	525.21	689.48	703.62	461.91	124.13
Receivables	20,548	19,278	17,187	13,547	14,878
Inventory	19,318	15,891	14,593	15,593	15,525
Prepaid Expenses	-	304.41	198.6	330.53	160.49
Other Current Assets	3,279	2,440	1,912	3,142	1,776
Total Current Assets	45,559	42,599	38,359	34,241	37,175
Property, Plant & Equipment	24,271	23,972	22,148	19,855	19,332
Long-Term Investments	193.36	186.94	557.78	440.37	10.99
Goodwill	3,678	3,787	2,177	2,174	3,975
Other Intangible Assets	5,792	5,078	1,258	1,614	3,832
Long-Term Deferred Tax Assets	1,110	967.96	991.26	1,161	1,483
Other Long-Term Assets	1,724	1,471	1,234	1,150	2,267
Total Assets	82,327	78,062	66,725	60,635	68,074
Accounts Payable	14,796	13,094	10,861	11,252	9,722
Accrued Expenses	545.12	3,366	2,782	2,457	2,612
Short-Term Debt	-	9,486	11,333	10,866	12,542
Current Portion of Long-Term Debt	5,418	3,721	3,175	2,797	3,623
Current Portion of Leases	337.28	319.19	241.9	222.96	324.43
Current Income Taxes Payable	1,123	534.45	487.75	621.52	616.91
Current Unearned Revenue	-	343.42	178.65	271.39	367.07
Other Current Liabilities	4,464	1,241	1,132	1,160	4,274
Total Current Liabilities	26,683	32,105	30,192	29,648	34,082
Long-Term Debt	1,899	7,666	7,441	7,173	7,040
Long-Term Leases	2,573	2,157	1,152	1,113	1,168
Long-Term Unearned Revenue	144.93	403.08	307.32	393.7	456.02
Long-Term Deferred Tax Liabilities	1,200	1,374	388.95	426.14	398.83
Other Long-Term Liabilities	3,411	3,139	747.37	739.54	1,249
Total Liabilities	35,912	46,844	40,229	39,493	44,394
Common Stock	1,895	1,812	1,809	1,809	1,809
Additional Paid-In Capital	-	98.84	-	-	840.37
Retained Earnings	-	26,980	22,789	17,751	19,191
Comprehensive Income & Other	42,567	632.25	413.54	315.91	890.31
Total Common Equity	44,462	29,523	25,011	19,875	22,730
Minority Interest	1,954	1,695	1,485	1,266	949.92
Shareholders' Equity	46,416	31,218	26,497	21,141	23,680
Total Liabilities & Equity	82,327	78,062	66,725	60,635	68,074
Total Debt	10,227	23,350	23,343	22,172	24,698
Net Cash (Debt)	-7,814	-18,663	-18,875	-20,544	-19,862
Net Cash Per Share	-41.78	-103.18	-104.37	-113.59	-109.82
Filing Date Shares Outstanding	189.53	181.15	180.85	180.85	180.85
Total Common Shares Outstanding	189.53	181.15	180.85	180.85	180.85
Working Capital	18,876	10,494	8,167	4,593	3,093
Book Value Per Share	234.60	162.97	138.30	109.90	125.68
Tangible Book Value	34,992	20,658	21,576	16,088	14,923
Tangible Book Value Per Share	184.63	114.04	119.30	88.96	82.52
Land	-	526.46	533.22	522.55	42.28
Buildings	-	5,972	5,478	4,901	4,609
Machinery	-	25,498	20,713	18,271	17,526
Construction In Progress	-	1,323	4,035	3,098	2,216
Leasehold Improvements	-	564.89	368.83	324.63	1,798

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.